Ethylone is primarily used in analytical, pharmacological, and forensic research due to its structural similarity to MDMA and other substituted cathinones. It serves as a reference compound in various scientific studies, especially those exploring synthetic stimulant analogs. Researchers employ Ethylone to understand its binding affinities, behavioral effects, and role in the neurochemical activity of synthetic empathogens.

• Structure–Activity Relationship (SAR) Studies
  Ethylone is analyzed to determine how slight structural modifications influence pharmacological activity. These insights help in understanding how different beta-keto analogs of MDMA affect serotonin, dopamine, and norepinephrine systems.

• Receptor Binding Assays
  Ethylone is used in binding assays to measure its affinity for monoamine transporters (e.g., SERT, DAT, and NET), helping researchers identify its psychoactive potential and compare it with known stimulants.

• Comparative Neurochemical Profiling
  Scientists study Ethylone alongside Methylone, Butylone, and MDMA to compare neurotransmitter release patterns, which assists in mapping its role in synthetic stimulant classification.

• Forensic Toxicology Reference Standard
  In forensic settings, Ethylone is used as a control substance for identifying synthetic cathinones in seized drug samples through GC-MS or LC-MS techniques.

• Legal Analog Analysis
  Legal analysts and policymakers reference Ethylone to understand how analog laws may apply to new cathinone derivatives. Its structural data serves as a legal and scientific benchmark.

• Toxicology and Risk Assessment
  While not consumed for safety reasons, cell culture or animal models help assess Ethylone’s toxic potential, contributing to the broader evaluation of synthetic stimulant safety profiles.

• Chemical Detection Development
  Analytical chemists use Ethylone in the development and refinement of drug testing protocols for law enforcement or workplace safety screening.

• Pharmacokinetic Modeling
  Ethylone is used in simulated environments to predict absorption, distribution, metabolism, and elimination (ADME) in theoretical models, offering insight into its duration and breakdown pathways.

Ethylone is not safe for human consumption and is sold strictly for research purposes. It has not undergone medical testing for human safety or therapeutic use. Any use outside laboratory settings is considered hazardous and may result in serious health consequences.

• Lack of Clinical Trials
  No clinical trials or toxicology studies in humans have been conducted to establish Ethylone’s safety, efficacy, or appropriate dosage for therapeutic use.

• Cardiovascular Risks
  Based on its similarity to stimulants like MDMA, Ethylone may pose risks such as elevated heart rate, hypertension, and vasoconstriction when consumed, especially in high doses.

• Neurotoxicity Concerns
  Animal studies suggest synthetic cathinones like Ethylone may cause dopaminergic or serotonergic neuron damage, potentially contributing to long-term cognitive or mood disorders.

• Unknown Long-Term Effects
  The long-term consequences of Ethylone exposure are not known due to the lack of longitudinal research, making any unregulated use extremely risky.

• Risk of Adulteration in Illicit Markets
  Street-sold Ethylone is often adulterated with unknown substances, increasing the danger of toxicity, overdose, or allergic reactions.

• Legal Prohibitions
  In many jurisdictions, human consumption of Ethylone is illegal, and possession or use may carry severe legal penalties.

• Lack of Medical Oversight
  No approved medical protocols exist for dosing, administering, or treating adverse reactions to Ethylone exposure in humans.

• Professional Use Only
  Ethylone is intended solely for trained personnel in licensed laboratories following strict chemical handling protocols and should never be used recreationally.

Ethylone is a synthetic cathinone and β-keto analog of MBDB, with a molecular structure that closely resembles Methylone and MDMA. Its core structure features a methylenedioxyphenyl ring, a beta-ketone group, and an ethylamino side chain.

• Beta-Keto Amphetamine Skeleton
  Ethylone contains a ketone group on the beta carbon of the amphetamine backbone, a key feature that influences its solubility and pharmacodynamics.

• Methylenedioxy Ring System
  The 1,3-benzodioxole ring contributes to its classification as a substituted methylenedioxyphenethylamine, similar to MDMA and MDA.

• Ethyl Substitution on the Amino Group
  The presence of an ethyl group instead of a methyl (as in Methylone) affects receptor binding affinity and slows onset of action.

• Molecular Formula: C12H15NO3
  This composition reflects 12 carbon atoms, 15 hydrogen atoms, one nitrogen, and three oxygen atoms—verified through molecular spectroscopy.

• Molecular Weight: 221.25 g/mol
  The precise molecular mass aids in analytical quantification and dose-response studies in chemical assays.

• Stereochemistry
  Ethylone can exist in chiral forms (enantiomers), though most lab-grade samples are racemic mixtures unless specified otherwise.

• Solubility in Organic Solvents
  Its solubility in both ethanol and water allows for flexible use in liquid chromatography or solution-based binding assays.

• Spectral Identification
  Its structure has been confirmed using IR spectroscopy, nuclear magnetic resonance (NMR), and gas chromatography–mass spectrometry (GC-MS).

Storing Ethylone properly is crucial to preserve its chemical stability, purity, and usability in research applications. Exposure to air, moisture, or light can degrade the compound, altering its integrity and research value.

• Keep in Airtight, Vacuum-Sealed Containers
  Ethylone should be stored in sealed containers that prevent air and moisture ingress to avoid oxidation or hydrolysis.

• Store in a Cool, Dry Environment
  Ideal storage temperature is below 25°C (77°F), away from direct sunlight and heat sources. Avoid environments with high humidity.

• Use Opaque or Amber-Colored Vials
  Protect the compound from UV light exposure by storing it in dark glass or light-resistant containers.

• Include Desiccants
  Silica gel packets or similar desiccants help absorb any residual moisture in the storage container, extending shelf life.

• Label Clearly
  Every container should include a label with the product name, batch number, storage date, and purity level to maintain traceability.

• Separate from Volatile Chemicals
  Ethylone should not be stored near acids, bases, or reactive chemicals that might compromise its structure.

• Avoid Frequent Reopening
  Minimize exposure to air by limiting how often the container is opened, especially if small samples are being taken repeatedly.

• Use Secondary Containment
  For long-term bulk storage, place the primary container in a sealed secondary case to protect against breakage and contamination.

Ethylone is classified differently depending on national laws. In many countries, it is treated as a controlled substance due to its structural similarity to MDMA and Methylone. Researchers must be aware of the laws in their respective jurisdictions before acquiring or handling Ethylone.

• United States (Schedule I Controlled Substance)
  Ethylone is federally banned in the U.S. and listed as a Schedule I drug under the Controlled Substances Act, meaning it has no recognized medical use and a high potential for abuse.

• Canada (Schedule III Substance)
  In Canada, Ethylone is regulated under Schedule III of the Controlled Drugs and Substances Act, making unauthorized possession or sale illegal.

• United Kingdom (Class B Drug)
  Ethylone is classified under the Misuse of Drugs Act as a Class B substance, rendering its sale, import, or possession without a license illegal.

• European Union (Varies by Country)
  While some EU member states explicitly list Ethylone as a banned substance, others regulate it under analogue laws that restrict structurally similar compounds.

• Australia and New Zealand
  These countries generally prohibit synthetic cathinones, including Ethylone, under psychoactive substance bans.

• Asia and Middle East
  Legal status varies widely. Some countries impose blanket bans on synthetic drugs, while others do not explicitly list Ethylone but may regulate it as an analogue.

• Researcher Responsibility
  Even if Ethylone is legal in your region, it is your responsibility to verify local regulations. Misuse can lead to fines, loss of licenses, or criminal charges.

• Psycho Plug’s Position
  We only sell Ethylone for research purposes and explicitly prohibit its use for consumption. We do not ship to countries where the compound is clearly banned.

While not commonly included in standard drug screening panels, Ethylone can be detected in extended or targeted drug tests. Due to its chemical similarity to Methylone and MDMA, it shares overlapping metabolic pathways, making it identifiable in forensic and clinical toxicology settings when appropriate tools are used.

• Not Detected in Routine 5-Panel Tests
  Most standard workplace drug screenings (e.g., THC, cocaine, opioids, amphetamines, PCP) do not include synthetic cathinones like Ethylone.

• Detected in Specialized Synthetic Cathinone Panels
  Advanced drug testing panels used in legal, military, or forensic cases may screen specifically for synthetic cathinones such as Ethylone.

• GC-MS and LC-MS Testing
  Gas chromatography–mass spectrometry (GC-MS) and liquid chromatography–mass spectrometry (LC-MS) can precisely identify Ethylone and its metabolites in blood, urine, or hair samples.

• Urine as the Preferred Sample
  Urine testing is most commonly used due to Ethylone’s excretion profile. It can typically be detected for 1–3 days post-exposure depending on dose and frequency.

• Cross-Reactivity With MDMA Panels
  Some immunoassay tests may yield false positives for MDMA due to structural similarity, especially in low-specificity test kits.

• Extended Detection in Hair Follicles
  Hair analysis can detect Ethylone for weeks to months after use. This method is often used in long-term forensic investigations or drug history profiling.

• Custom Lab Screening Required
  For accurate and specific detection, labs must use certified reference materials for Ethylone and its primary metabolites.

• Metabolite Identification
  Major metabolites include 3,4-dihydroxy-N-ethylcathinone and its conjugates, which can also be screened to confirm Ethylone exposure.

Ethylone is structurally and functionally related to both Methylone and MDMA but differs in potency, receptor interaction, and duration. It’s often studied alongside these compounds to better understand stimulant-empathogen hybrids and their mechanisms of action.

• Structural Differences
  Ethylone and Methylone are both β-keto analogs of MDMA, but Ethylone has an ethyl group on the amine, while Methylone has a methyl group. This minor difference affects absorption, onset, and neurotransmitter selectivity.

• Receptor Affinity
  Ethylone is more dopaminergic than serotonergic compared to MDMA, which has higher serotonin release activity. This makes Ethylone more stimulating and less emotionally immersive.

• Onset and Duration
  Ethylone generally has a slower onset and longer duration than Methylone, making it more suitable for sustained stimulant research applications.

• Empathogenic vs. Stimulant Effects
  MDMA produces profound empathogenic and euphoric effects, while Ethylone leans more toward alertness and stimulation, with less emotional depth.

• Potency Level
  Ethylone is slightly less potent than MDMA by weight but stronger than Butylone. Methylone is often considered closer in psychoactivity to MDMA than Ethylone.

• Neurotoxicity Profiles
  While all three compounds may exert neurotoxic effects, Ethylone’s profile is less understood. MDMA’s risks are more documented in literature, whereas Ethylone’s remain under investigation.

• Forensic Application
  Ethylone, Methylone, and MDMA are commonly tested together in forensic labs to trace analog use and street-level drug formulations.

• Legal Categorization
  All three compounds are banned in many countries, often classified similarly due to their chemical closeness and potential misuse.

Ethylone was first synthesized in the early 2000s as part of a wave of new psychoactive substances (NPS) designed to mimic the effects of MDMA while evading existing drug laws. It emerged as a designer drug before being regulated in most countries and now serves as a compound of interest in research and forensic science.

• Beta-Keto Derivative of MBDB
  Ethylone was chemically engineered as the β-keto analog of MBDB, a compound structurally related to MDMA, making it part of the synthetic cathinone class.

• Rise in the Early 2010s
  Ethylone began appearing in online “legal high” markets and head shops during the early 2010s, often sold as a safer or legal alternative to MDMA.

• Marketed Under False Labels
  Vendors often sold Ethylone as “bath salts,” “research chemicals,” or “plant food” to bypass regulation, despite it being intended for consumption.

• Widespread Use Triggered Legal Response
  As incidents involving Ethylone and related compounds increased, governments worldwide moved to schedule it under controlled substances laws.

• Increased Interest from Researchers
  After being scheduled, Ethylone gained traction in forensic and pharmacological studies for its similarities and distinctions from Methylone and MDMA.

• Now Used for Analytical Purposes
  It is currently employed in laboratories as a comparator in drug testing method development and chemical behavior modeling.

• Part of Broader Cathinone Classification
  Ethylone’s rise mirrored that of other synthetic cathinones like Butylone, Pentylone, and Naphyrone, which were also introduced in the designer drug era.

Ethylone’s physical effects have been observed primarily through rodent models and in vitro systems. While it has not been approved for human trials, certain physiological responses have been documented in research and anecdotal contexts.

• Increased Heart Rate and Blood Pressure
  As a stimulant, Ethylone promotes heightened cardiovascular activity. Elevated heart rate and systolic blood pressure have been noted in dose-response studies.

• Mydriasis (Pupil Dilation)
  Ethylone often causes pupil dilation, which is a common sympathetic nervous system response to stimulants.

• Mild Hyperthermia
  Studies indicate a moderate rise in body temperature during high-dose exposure, though not as severe as that observed with MDMA.

• Appetite Suppression
  Rodents exposed to Ethylone demonstrated reduced food intake, consistent with its action on norepinephrine and dopamine pathways.

• Motor Stimulation
  Locomotion tracking in rats shows increased activity, indicating typical stimulant-like physical activation.

• Jaw Clenching and Muscle Tension
  Anecdotal reports and animal studies both suggest increased muscle tone and potential bruxism (jaw clenching) under Ethylone exposure.

• Tremors and Restlessness at High Doses
  At higher concentrations, test subjects show signs of tremors, agitation, or erratic movement patterns, indicating possible excitotoxicity.

• Limited Duration Compared to MDMA
  Ethylone’s physical effects often persist for 3–6 hours depending on the dose, making it less prolonged than MDMA.

Although Ethylone has not been studied extensively in humans due to legal and ethical constraints, preclinical models and anecdotal human reports provide insight into its psychological impact. It is generally characterized by increased stimulation, heightened alertness, and mild mood elevation.

• Stimulant-Induced Euphoria
  Behavioral models show that Ethylone promotes increased responsiveness to stimuli, often linked to dopamine release in reward pathways.

• Mild Empathogenic Qualities
  Ethylone can induce increased sociability and lowered anxiety in controlled lab environments, though to a lesser extent than MDMA.

• Increased Motivation and Goal-Directed Activity
  Lab rats demonstrate heightened goal-oriented behavior and reduced fatigue, suggesting dopamine-dominant central activity.

• Attention and Cognitive Enhancement
  Some evidence indicates temporary improvements in focus and short-term memory performance in stimulant-exposed subjects.

• Reduced Inhibition
  Preclinical behavioral inhibition tests show reduced anxiety-like behavior, though this may be dose-dependent and inconsistent.

• Potential for Anxiety or Paranoia
  Higher doses may produce overstimulation leading to anxious behavior or restlessness in test subjects.

• Lack of Emotional Depth
  Compared to MDMA, Ethylone produces less emotional resonance or psychological introspection, which is consistent with its lower serotonergic activity.

• No Hallucinogenic Effects
  Unlike classical psychedelics, Ethylone does not activate 5-HT2A receptors and thus lacks hallucinatory or dissociative properties.

The shelf life and chemical stability of Ethylone are critical for maintaining its integrity in research and laboratory environments. When stored properly under controlled conditions, Ethylone retains its potency and molecular structure over time, ensuring reliable and consistent outcomes in analytical studies.

• Typical Shelf Life: 18–24 Months
  Under optimal conditions (cool, dry, and sealed), Ethylone maintains full potency for up to two years. After this period, degradation may begin depending on environmental factors.

• Highly Stable in Crystalline Form
  Ethylone is most stable in its raw powder/crystalline state. Liquid solutions or dissolved forms degrade faster and are not recommended for long-term storage.

• Sensitive to Moisture and Humidity
  Exposure to ambient moisture accelerates hydrolysis and may cause clumping, discoloration, or chemical instability. Always store with desiccants in an airtight container.

• Temperature-Controlled Storage is Essential
  Store Ethylone at temperatures below 25°C (77°F). Excess heat can cause breakdown of active compounds or accelerate oxidation.

• Light Exposure Degrades Potency
  UV and fluorescent light can deteriorate Ethylone’s molecular bonds. It should be kept in amber-colored or opaque containers.

• Batch Degradation Indicators
  Changes in color (from white to yellow or brown), abnormal odor, or sticky texture are clear signs of degradation and should prompt disposal.

• Use-by Date Should Be Documented
  Laboratories are advised to label all containers with manufacturing and expiration dates to monitor compound usability.

• Chemical Testing Recommended After Long Storage
  If a batch is older than 12 months, re-analysis with FTIR or HPLC is recommended to confirm that no degradation or contamination has occurred.

While Ethylone is not intended for human consumption, laboratory settings use precise dosing guidelines to ensure accurate chemical and pharmacological research. All dosage references are strictly related to lab-based procedures such as spectroscopy, chromatography, and biological assays.

• Common Analytical Range: 5–100 mg
  Most laboratories use small quantities of Ethylone (typically under 100 mg) for each assay, depending on sensitivity and equipment type.

• Microgram-Level for Binding Studies
  In receptor affinity assays and pharmacological binding studies, Ethylone is used in microgram or nanomolar concentrations to measure its interaction with specific neurotransmitter transporters.

• High-Performance Liquid Chromatography (HPLC) Sample Prep
  Ethylone is dissolved in ethanol, methanol, or deionized water to prepare solutions of known concentration for quantification via HPLC.

• Titration and Dilution for Pharmacokinetics
  For kinetic studies or tissue exposure, researchers may perform serial dilutions to determine the effect of various concentrations on biological substrates.

• Strictly Non-Human Use
  Any reference to dosage in lab use has no applicability to human use or self-experimentation. The compound is untested, unregulated, and unsafe for ingestion.

• Digital Scales Required for Precision
  Ethylone must be weighed using analytical balances accurate to at least 0.1 mg. Manual scooping or volumetric estimation is not suitable.

• Avoid Overhandling of Stock Batches
  Each dose should be prepared from a clean subsample. Repeated exposure of the main container to air can introduce moisture or contaminants.

• Disposal of Unused Solutions
  Ethylone solutions should be discarded according to hazardous waste protocols after use. They are not suitable for long-term storage unless refrigerated and sealed.

Handling Ethylone safely is vital to minimize chemical exposure risks and maintain laboratory integrity. Researchers must follow chemical hygiene protocols when working with any psychoactive or synthetic cathinone compound.

• Always Wear Personal Protective Equipment (PPE)
  Lab coat, gloves (nitrile recommended), and eye protection should be worn at all times. If working with powders, a mask or respirator should be considered to prevent inhalation.

• Use Fume Hoods for Open Work
  Weighing, dissolving, or transferring Ethylone should be done in a ventilated fume hood to prevent airborne particle exposure.

• Avoid Skin Contact and Inhalation
  Ethylone can be absorbed through skin or mucous membranes. Any contact should be immediately rinsed with water, and contaminated clothing should be removed.

• Do Not Ingest or Allow Cross-Contamination
  Ethylone is not food-safe and should be kept away from any area where food or drink is handled. Cross-contamination with other chemicals can be hazardous.

• Clean Work Surfaces and Tools Thoroughly
  After handling, surfaces should be disinfected, and all instruments (scales, scoops, containers) should be washed or replaced to prevent residue build-up.

• Label All Containers Clearly
  Each storage vial or bag must be labeled with the compound name, concentration (if in solution), hazard warnings, and handling date.

• Secure Storage Access
  Ethylone should be stored in a locked cabinet or refrigerator accessible only to authorized personnel.

• Follow Local Chemical Safety Protocols
  Comply with institutional or national guidelines (such as OSHA, WHMIS, or REACH) regarding the handling, transport, and disposal of psychoactive research chemicals.

Verifying the quality of Ethylone ensures that research results are valid, consistent, and legally defensible. Proper testing eliminates the risk of using adulterated or mislabeled compounds, which can compromise experiments or violate regulatory requirements.

• Request a Certificate of Analysis (COA)
  A COA from Psycho Plug includes details on the chemical’s purity, synthesis method, testing protocols (e.g., HPLC, GC-MS), and impurity levels.

• Use Infrared Spectroscopy (FTIR)
  FTIR analysis confirms functional groups in the Ethylone molecule and compares spectra against known standards to confirm identity.

• Perform High-Performance Liquid Chromatography (HPLC)
  HPLC is used to quantify Ethylone’s purity and detect contaminants or related compounds such as Butylone or Methylone.

• Test with GC-MS
  Gas chromatography–mass spectrometry offers one of the most accurate means of verifying compound composition and identifying degradation byproducts.

• Melting Point Analysis
  Ethylone has a distinct melting point in the range of 150–160°C. Deviations from this point may indicate impurity or substitution.

• Visual and Physical Inspection
  Pure Ethylone typically appears as a fine, crystalline white to off-white powder. Any unusual texture, color, or odor may indicate contamination.

• Reagent Testing for Field Verification
  In field or non-lab environments, reagent tests (e.g., Marquis, Mecke) can offer a basic identity check, though they are not definitive or quantitative.

• Maintain Reference Standards for Comparison
  Laboratories often keep authenticated samples of pure Ethylone for side-by-side comparison when receiving new batches.

Yes, like many synthetic compounds, Ethylone can degrade over time, particularly when exposed to poor storage conditions. Degradation not only reduces potency but may result in the formation of unknown or harmful byproducts that compromise safety and research integrity.

• Oxidation is the Primary Degradation Mechanism
  Exposure to air causes Ethylone to oxidize, particularly at the ketone group, leading to molecular breakdown and potential formation of inactive or toxic compounds.

• Moisture Promotes Hydrolysis
  Humidity or condensation can cause the β-keto group to hydrolyze, altering the structure and rendering the compound unusable for accurate research.

• UV Light Triggers Photodegradation
  Ultraviolet exposure can break down the methylenedioxy ring system, a key structural feature in Ethylone, thus destroying its chemical identity.

• Color Changes as a Red Flag
  If the powder changes from white/off-white to yellow, beige, or brown, it may indicate chemical decomposition or contamination.

• Formation of Unknown Compounds
  Degraded Ethylone may yield unknown byproducts that have not been safety-tested, creating risk during handling or analysis.

• Impacts on Research Validity
  Using degraded Ethylone skews research results, potentially invalidating experiments or leading to incorrect conclusions about pharmacological effects.

• Risk of Hazardous Gases or Odors
  In extreme cases of degradation, off-gassing or chemical odors may occur, indicating the presence of volatile breakdown compounds.

• Best Practice: Re-Test After 12 Months
  Even when stored correctly, older batches should be subjected to quality verification (e.g., HPLC or FTIR) before use in sensitive studies.